Skip to content

Clinical trials

Completed Phase 1/2 Major Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 1/2 Status: Completed Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20052
20061
20071
20091
20101
20112
20121
20142
20152
20161
20172
20186
20192
20213
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical Research Council Cognition and Brain Sciences Unit2
New York State Psychiatric Institute2
Alkermes, Inc.1
Bristol-Myers Squibb1
Centre for Addiction and Mental Health1
Cybin IRL Limited1
Dart NeuroScience, LLC1
Duke University1
GH Research Ireland Limited1
Hadassah Medical Organization1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder34
Dysthymic Disorder3
Stress Disorders, Post-Traumatic3
Alcoholism2
Bipolar Disorder2
Generalized Anxiety Disorder2
Mood Disorders2
Panic Disorder2
Phobia, Social2
Adjustment Disorders1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.